Julie Kim is due to be promoted to chief executive of Takeda Pharmaceutical Co. next year. First, though, the head of the Japanese drugmaker’s US operations had some business advice to share ...

OSAKA, Japan & CAMBRIDGE, Mass., January 30, 2025--Takeda (TOKYO:4502/NYSE:TAK) announced today that its Board of Directors made the decision unanimously to appoint Julie Kim, currently president ...

Takeda has announced the appointment of Julie Kim as successor to Christophe Weber, its current president, CEO and representative director, effective from June 2026. The decision was unanimously ...

Takeda Pharmaceutical 4502 0.21 % increase; green up pointing triangle named Julie Kim, who heads its U.S. business, as its new chief executive starting in 2026, ...

Julie Kim is set to replace Christophe Weber as the new chief executive officer of Takeda Pharmaceutical Co., becoming the first woman to lead the more than 240-year-old Japanese drugmaker.

Learn more about Julie Kim, a financial advisor in Newport Beach, CA with the US News Advisor Finder.

Takeda has named Julie Kim as its next CEO. She will replace Christophe Weber who plans to step down in June of 2026 after leading Japan’s largest drugmaker for 11 years.

Julie Kim, Clinical Social Work/Therapist, Costa Mesa, CA, 92626, (858) 780-5164, I am a licensed clinical social worker based in California with a Masters in Social Work from Columbia University ...

When Julie Kim ’97 MBA graduated from the Kellogg School of Management, buzzwords like purpose, engagement and connection weren’t yet popular in professional circles. But in retrospect, she says, ...

Julie Kim, president of the U.S. Business Unit, named to succeed Weber after multi-year succession process; January 30, 2025 02:04 AM Eastern Standard Time.

Takeda Pharmaceutical named Julie Kim, who heads its U.S. business, as its new chief executive starting in 2026, elevating her to the small but growing ranks of women leading Japanese companies ...